CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Cimetidine

西咪替丁 杂质对照品Cimetidine Impurities

EP30 个杂质条目30 impurity entries

本页汇总 西咪替丁 的 30 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 30 impurity reference standards of Cimetidine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 西咪替丁(Cimetidine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDetermination of cimetidine and related impurities in pharmaceutical formulations by high-performance liquid chromatography
    Journal of chromatography · 1991 · Betto P et al.  ·  PMID 1806550  ·  DOI
  2. 杂质研究Impurity studiesColorimetric assay of cimetidine in the presence of its oxidative degradates
    Journal of AOAC International · 2009 · Amin AS et al.  ·  PMID 19485195
  3. 杂质研究Impurity studiesSpectrophotometric determination of cimetidine in the presence of its acid-induced degradation products
    Journal of pharmaceutical and biomedical analysis · 1991 · Bedair MM et al.  ·  PMID 1911980  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and validation of a RP-HPLC method for simultaneous determination of cimetidine, metoprolol tartrate and phenol red for intestinal perfusion studies
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2025 · Ermis M et al.  ·  PMID 39787726  ·  DOI
  5. 分析方法Analytical MethodsDevelopment of an HPLC method for the determination of ranitidine and cimetidine in human plasma following SPE
    Journal of pharmaceutical and biomedical analysis · 2003 · Zendelovska D, Stafilov T  ·  PMID 12972081  ·  DOI

西咪替丁 —— 原料药与杂质对照品Cimetidine — drug substance & impurities

共 31 个条目(含原料药本体)31 items incl. the drug substance
Cimetidine structure
EP原料药 APIAPI
西咪替丁Cimetidine
Cimetidine
CAS No.51481-61-9
Chemical FormulaC10H16N6S
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 1(Cimetidine EP Impurity A) structure
EPA
西咪替丁杂质1(西咪替丁EP杂质A)Cimetidine Impurity 1(Cimetidine EP Impurity A)
Cimetidine Impurity 1(Cimetidine EP Impurity A)
CAS No.52378-40-2
Chemical FormulaC10H15N5S2
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 2(Cimetidine EP Impurity B) structure
EPB
西咪替丁杂质2(西咪替丁EP杂质B)Cimetidine Impurity 2(Cimetidine EP Impurity B)
Cimetidine Impurity 2(Cimetidine EP Impurity B)
CAS No.138035-55-9
Chemical FormulaC10H15N5OS
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 3 (Cimetidine EP Impurity C) structure
EPC
西咪替丁杂质3 (西咪替丁EP杂质C)Cimetidine Impurity 3 (Cimetidine EP Impurity C)
Cimetidine Impurity 3 (Cimetidine EP Impurity C)
CAS No.52568-80-6
Chemical FormulaC10H18N6OS·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 4 (Cimetidine EP Impurity D) structure
EPD
西咪替丁杂质4 (西咪替丁EP杂质D)Cimetidine Impurity 4 (Cimetidine EP Impurity D)
Cimetidine Impurity 4 (Cimetidine EP Impurity D)
CAS No.59660-24-1
Chemical FormulaC9H17N5S·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 5(Cimetidine EP Impurity E) structure
EPE
西咪替丁杂质5(西咪替丁EP杂质E)Cimetidine Impurity 5(Cimetidine EP Impurity E)
Cimetidine Impurity 5(Cimetidine EP Impurity E)
CAS No.54237-72-8
Chemical FormulaC10H16N6OS
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 6 (Cimetidine EP Impurity F) structure
EPF
西咪替丁杂质6 (西咪替丁EP杂质F)Cimetidine Impurity 6 (Cimetidine EP Impurity F)
Cimetidine Impurity 6 (Cimetidine EP Impurity F)
CAS No.55272-86-1
Chemical FormulaC16H24N8S2
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 7(Cimetidine EP Impurity G) structure
EPG
西咪替丁杂质7(西咪替丁EP杂质G)Cimetidine Impurity 7(Cimetidine EP Impurity G)
Cimetidine Impurity 7(Cimetidine EP Impurity G)
CAS No.31857-31-5
Chemical FormulaC4H8N4
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 8(Cimetidine EP Impurity H) structure
EPH
西咪替丁杂质8(西咪替丁EP杂质H)Cimetidine Impurity 8(Cimetidine EP Impurity H)
Cimetidine Impurity 8(Cimetidine EP Impurity H)
CAS No.74886-59-2
Chemical FormulaC10H18N8S2
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 15 (Cimetidine EP Impurity I) structure
EPI
西咪替丁杂质15 (西咪替丁EP杂质I)Cimetidine Impurity 15 (Cimetidine EP Impurity I)
Cimetidine Impurity 15 (Cimetidine EP Impurity I)
CAS No.29636-87-1
Chemical FormulaC5H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 15 Hydrochloride (Cimetidine EP Impurity I Hydrochloride) structure
EPI
西咪替丁杂质15 盐酸盐 (西咪替丁EP杂质I 盐酸盐)Cimetidine Impurity 15 Hydrochloride (Cimetidine EP Impurity I Hydrochloride)
Cimetidine Impurity 15 Hydrochloride (Cimetidine EP Impurity I Hydrochloride)
CAS No.38585-62-5
Chemical FormulaC5H8N2O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 10 Monomer (Cimetidine EP Impurity J) structure
EPJ
西咪替丁杂质10 单体 (西咪替丁EP杂质J 单体)Cimetidine Impurity 10 Monomer (Cimetidine EP Impurity J)
Cimetidine Impurity 10 Monomer (Cimetidine EP Impurity J)
CAS No.38585-67-0
Chemical FormulaC7H13N3S
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 10 (Cimetidine EP Impurity J Monomer) structure
EPJ
西咪替丁杂质10 (西咪替丁EP杂质J 单体)Cimetidine Impurity 10 (Cimetidine EP Impurity J Monomer)
Cimetidine Impurity 10 (Cimetidine EP Impurity J Monomer)
CAS No.38603-72-4
Chemical FormulaC7H13N3S·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 10 Dihydrobromide (Cimetidine EP Impurity J Dihydrobromide) structure
EPJ
西咪替丁杂质10 双氢溴酸盐 (西咪替丁EP杂质J 双氢溴酸盐)Cimetidine Impurity 10 Dihydrobromide (Cimetidine EP Impurity J Dihydrobromide)
Cimetidine Impurity 10 Dihydrobromide (Cimetidine EP Impurity J Dihydrobromide)
CAS No.38603-73-5
Chemical FormulaC7H13N3S·2HBr
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 3 structure
3
西咪替丁杂质3Cimetidine Impurity 3
Cimetidine Impurity 3
CAS No.10191-60-3
Chemical FormulaC4H6N2S2
Purity>95%现货In stock
10mg25mg50mg100mg
Cimetidine Impurity 9 structure
9
西咪替丁杂质9Cimetidine Impurity 9
Cimetidine Impurity 9
CAS No.38603-74-6
Chemical FormulaC6H10N2O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 11 structure
11
西咪替丁杂质11Cimetidine Impurity 11
Cimetidine Impurity 11
CAS No.1609-06-9
Chemical FormulaC4H8N4
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 12 structure
12
西咪替丁杂质12Cimetidine Impurity 12
Cimetidine Impurity 12
CAS No.75850-09-8
Chemical FormulaC12H19N5OS
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 13 structure
13
西咪替丁杂质13Cimetidine Impurity 13
Cimetidine Impurity 13
CAS No.208447-53-4
Chemical FormulaC11H20N8S2
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 16 structure
16
西咪替丁杂质16Cimetidine Impurity 16
Cimetidine Impurity 16
CAS No.3201-22-7
Chemical FormulaC5H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 17 structure
17
西咪替丁杂质17Cimetidine Impurity 17
Cimetidine Impurity 17
CAS No.59593-35-0
Chemical FormulaC5H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 19 structure
19
西咪替丁杂质19Cimetidine Impurity 19
Cimetidine Impurity 19
CAS No.182685-55-8
Chemical FormulaC16H26N10S2
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 20 structure
20
西咪替丁杂质20Cimetidine Impurity 20
Cimetidine Impurity 20
CAS No.2384-02-3
Chemical FormulaC6H6N4
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 21 structure
21
西咪替丁杂质21Cimetidine Impurity 21
Cimetidine Impurity 21
CAS No.492-98-8
Chemical FormulaC6H6N4
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 25 structure
25
西咪替丁杂质25Cimetidine Impurity 25
Cimetidine Impurity 25
CAS No.82069-10-1
Chemical FormulaC10H15N7OS
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 26 structure
26
西咪替丁杂质26Cimetidine Impurity 26
Cimetidine Impurity 26
CAS No.44565-47-1
Chemical FormulaC4H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 27 structure
27
西咪替丁杂质27Cimetidine Impurity 27
Cimetidine Impurity 27
CAS No.37570-85-7
Chemical FormulaC7H8N4
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 28 structure
28
西咪替丁杂质28Cimetidine Impurity 28
Cimetidine Impurity 28
CAS No.37570-94-8
Chemical FormulaC8H10N4
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 29 (N1-Nitroso Cimetidine) structure
29
西咪替丁杂质29 (N1-亚硝基西咪替丁)Cimetidine Impurity 29 (N1-Nitroso Cimetidine)
Cimetidine Impurity 29 (N1-Nitroso Cimetidine)
CAS No.73785-40-7
Chemical FormulaC10H15N7OS
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 30 (N2-Nitroso Cimetidine) structure
30
西咪替丁杂质30 (N2-亚硝基西咪替丁)Cimetidine Impurity 30 (N2-Nitroso Cimetidine)
Cimetidine Impurity 30 (N2-Nitroso Cimetidine)
CAS No.87602-17-3
Chemical FormulaC10H15N7OS
Purity>95%询价On request
10mg25mg50mg100mg
Cimetidine Impurity 31 structure
31
西咪替丁杂质31Cimetidine Impurity 31
Cimetidine Impurity 31
CAS No.51605-32-4
Chemical FormulaC7H10N2O2
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

西咪替丁 —— 研究文献与合成路线Cimetidine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 西咪替丁 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Cimetidine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Cimetidine promotes STUB1-mediated degradation of tumoral FOXP3 by activating PI3K-Akt pathway in gastric cancer
    Zhang L, Li Q, Xu J, et al. · Annals of translational medicine · 2020 · 被引 8cited 8
  2. Estimation of impurity profiles of drugs and related materials Part 15. Identification of minor impurities in cimetidine
    Halmos Z, Szántay C, Brlik J, et al. · Journal of pharmaceutical and biomedical analysis · 1996 · 被引 7cited 7
  3. Determination of cimetidine and related impurities in pharmaceutical formulations by high-performance liquid chromatography
    Betto P, Ciranni-Signoretti E, Di Fava R · Journal of chromatography · 1991 · 被引 4cited 4
  4. Colorimetric assay of cimetidine in the presence of its oxidative degradates
    Amin AS, Dessouki HA, Shama SA, et al. · Journal of AOAC International · 2009 · 被引 1cited 1
  5. Spectrophotometric determination of cimetidine in the presence of its acid-induced degradation products
    Bedair MM, Elsayed MA, Korany MA, et al. · Journal of pharmaceutical and biomedical analysis · 1991 · 被引 2cited 2
  6. Determination of submicrogram quantities of cimetidine and its biotransformation and degradation products
    Jenko B, Kosak A, Milivojevic D, et al. · Agents and actions · 1983 · 被引 2cited 2

合成与制备工艺专利Synthesis & process patents

  1. Cimetidine emulsion for treating esophagitis and gastropathy and preparation thereof
    FUPING LAI · 公开号 CN101264055CN101264055 · 2008
  2. Application of cimetidine, ribavirin, chlorpheniramine maleate, vitamin B12 and amidopyrine in preparing medicine for treating herpes zoster
    WENSHENG WANG · 公开号 CN101167737CN101167737 · 2008
  3. NOVEL CIMETIDINE POLYMORPH AND PROCESS FOR PREPARING SAME
    JESZENSZKY Andor, V GH Ferenc, BENCSIK Péter, NAGY Lßszl¾, et al. · 公开号 EP0571463EP0571463 · 1993
  4. NOVEL CIMETIDINE POLYMORPH AND PROCESS FOR PREPARING SAME
    JESZENSZKY ANDOR, VEGH FERENC, BENCSIK PETER, NAGY LASZLO, et al. · 公开号 WO9214713WO9214713 · 1992
  5. A process for the preparation of cimetidine
    Zizek Teofil M. Sc · 公开号 EP0279161EP0279161 · 1988

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

西咪替丁 杂质谱研究要点Cimetidine — impurity profiling notes

下面这些是拿到 西咪替丁 的 31 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 31 impurity entries for Cimetidine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances